Kineta, Inc. Banner Image

Kineta, Inc. has reached its limit for free report views

Work for Kineta, Inc.? Upgrade Your Profile and unlock all your annual reports.

Kineta, Inc.

  • Ticker KA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kineta, Inc. Logo Image
  • 11-50 Employees
  • Based in Seattle, Washington
Kineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy.
4.8 / 5.0 (102)

Kineta, Inc. reports have an aggregate usefulness score of 4.8 based on 102 reviews.

Kineta, Inc.

Most Recent Annual Report

Kineta, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Kineta, Inc. has reached its limit for free report views.

Older/Archived Annual Reports

Kineta, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!